Quality of Life in Brain Metastases Radiation Trials: A Literature Review
Author Information
Author(s): Wong J., Hird A., Kirou–Mauro A., Napolskikh J., Chow E.
Primary Institution: Sunnybrook Health Sciences Centre, University of Toronto
Hypothesis
How have previous trials utilized quality of life tools to evaluate the efficacy of whole-brain radiotherapy for brain metastases?
Conclusion
The review highlights the need for standardized quality of life measures in future clinical trials for brain metastases.
Supporting Evidence
- 55 of the trials employed a quality of life instrument, but few focused on quality of life as an outcome.
- 14 trials included an evaluation of the study population’s quality of life.
- Some studies reported deterioration in quality of life after whole-brain radiotherapy in patients with poorer prognosis.
Takeaway
This study looked at how well patients with brain cancer feel after treatment. It found that some patients feel better after treatment, while others feel worse.
Methodology
A systematic search of Medline and Cochrane databases was conducted to identify trials involving whole-brain radiotherapy for brain metastases.
Potential Biases
High attrition rates may lead to bias, as patients who drop out may have poorer prognoses.
Limitations
The review found a lack of standardized quality of life instruments across studies, making comparisons difficult.
Participant Demographics
The studies included adult participants diagnosed with one or more brain metastases.
Statistical Information
Confidence Interval
95% confidence interval: 13%–43%
Want to read the original?
Access the complete publication on the publisher's website